Completed
A Phase II, prospective, open-label, pilot study of the tolerability, safety, and efficacy of Argon plasma coagulation for the treatment of anal intraepithelial neoplasia grade 2 or 3 in HIV-positive men having sex with men
Learn MoreEnrolling
Using a novel assay to detect syphilis infection early in asymptomatic men who have sex with men (MSM) undergoing STI screening
Learn MoreCompleted
Feasibility of Crystal Methamphetamine Interventions Among Gay, Bisexual and Other Men Who Have Sex With Men in Canada
Learn MoreReporting
A pilot study of a novel, mRNA-based assay for the diagnosis of anal HPV infection HIV-positive MSM
Learn MoreCompleted
The impact of in-clinic follow-up with a sexologist on the sexual health of HIV-serodiscordant MSM couples
Learn MoreReporting
SPOT, a rapid HIV testing intervention for MSM: measuring the impact of counselling on sexual risk behaviours
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
